nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A1—kidney cancer	0.299	1	CbGaD
Flutamide—CYP1B1—Erlotinib—kidney cancer	0.069	0.146	CbGbCtD
Flutamide—CYP1B1—Paclitaxel—kidney cancer	0.0632	0.134	CbGbCtD
Flutamide—CYP3A5—Temsirolimus—kidney cancer	0.0485	0.103	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—kidney cancer	0.0341	0.0721	CbGbCtD
Flutamide—CYP1A1—Erlotinib—kidney cancer	0.0303	0.0641	CbGbCtD
Flutamide—CYP3A4—Everolimus—kidney cancer	0.028	0.0593	CbGbCtD
Flutamide—CYP1A2—Pazopanib—kidney cancer	0.019	0.0402	CbGbCtD
Flutamide—CYP3A4—Temsirolimus—kidney cancer	0.0189	0.0401	CbGbCtD
Flutamide—CYP3A5—Erlotinib—kidney cancer	0.0182	0.0385	CbGbCtD
Flutamide—CYP3A5—Paclitaxel—kidney cancer	0.0166	0.0352	CbGbCtD
Flutamide—CYP3A5—Sorafenib—kidney cancer	0.0148	0.0313	CbGbCtD
Flutamide—CYP3A5—Vincristine—kidney cancer	0.0143	0.0304	CbGbCtD
Flutamide—CYP1A2—Erlotinib—kidney cancer	0.0135	0.0287	CbGbCtD
Flutamide—CYP3A5—Sunitinib—kidney cancer	0.012	0.0254	CbGbCtD
Flutamide—CYP2C19—Sorafenib—kidney cancer	0.0119	0.0253	CbGbCtD
Flutamide—CYP1A2—Sorafenib—kidney cancer	0.011	0.0233	CbGbCtD
Flutamide—CYP3A4—Pazopanib—kidney cancer	0.00993	0.021	CbGbCtD
Flutamide—CYP3A4—Erlotinib—kidney cancer	0.00709	0.015	CbGbCtD
Flutamide—CYP3A4—Paclitaxel—kidney cancer	0.00649	0.0137	CbGbCtD
Flutamide—CYP3A4—Sorafenib—kidney cancer	0.00576	0.0122	CbGbCtD
Flutamide—CYP3A4—Vinblastine—kidney cancer	0.00569	0.0121	CbGbCtD
Flutamide—CYP3A4—Vincristine—kidney cancer	0.0056	0.0119	CbGbCtD
Flutamide—CYP3A4—Sunitinib—kidney cancer	0.00467	0.00989	CbGbCtD
Flutamide—CYP3A4—Doxorubicin—kidney cancer	0.0035	0.00741	CbGbCtD
Flutamide—CYP2C19—urine—kidney cancer	0.00293	0.119	CbGeAlD
Flutamide—CYP1A2—urine—kidney cancer	0.00239	0.0971	CbGeAlD
Flutamide—CYP3A4—urine—kidney cancer	0.00173	0.0703	CbGeAlD
Flutamide—AHR—nephron tubule—kidney cancer	0.00172	0.07	CbGeAlD
Flutamide—AHR—cortex of kidney—kidney cancer	0.00147	0.0599	CbGeAlD
Flutamide—AHR—cardiac atrium—kidney cancer	0.0014	0.057	CbGeAlD
Flutamide—CYP1B1—nephron tubule—kidney cancer	0.000897	0.0365	CbGeAlD
Flutamide—CYP1B1—renal system—kidney cancer	0.000816	0.0332	CbGeAlD
Flutamide—CYP1B1—kidney—kidney cancer	0.000789	0.032	CbGeAlD
Flutamide—AR—renal system—kidney cancer	0.000773	0.0314	CbGeAlD
Flutamide—CYP1B1—cortex of kidney—kidney cancer	0.000768	0.0312	CbGeAlD
Flutamide—AR—kidney—kidney cancer	0.000747	0.0304	CbGeAlD
Flutamide—CYP1B1—gonad—kidney cancer	0.000732	0.0297	CbGeAlD
Flutamide—AR—cortex of kidney—kidney cancer	0.000727	0.0296	CbGeAlD
Flutamide—AR—gonad—kidney cancer	0.000693	0.0282	CbGeAlD
Flutamide—AR—cardiac atrium—kidney cancer	0.000692	0.0281	CbGeAlD
Flutamide—CYP3A5—nephron tubule—kidney cancer	0.00062	0.0252	CbGeAlD
Flutamide—CYP1A2—renal system—kidney cancer	0.000585	0.0238	CbGeAlD
Flutamide—CYP1A1—renal system—kidney cancer	0.000577	0.0234	CbGeAlD
Flutamide—CYP3A5—renal system—kidney cancer	0.000564	0.0229	CbGeAlD
Flutamide—CYP1A1—kidney—kidney cancer	0.000558	0.0227	CbGeAlD
Flutamide—CYP3A5—kidney—kidney cancer	0.000545	0.0222	CbGeAlD
Flutamide—CYP3A5—cortex of kidney—kidney cancer	0.000531	0.0216	CbGeAlD
Flutamide—CYP1A1—cardiac atrium—kidney cancer	0.000516	0.021	CbGeAlD
Flutamide—CYP3A4—renal system—kidney cancer	0.000423	0.0172	CbGeAlD
Flutamide—CYP3A4—kidney—kidney cancer	0.000409	0.0166	CbGeAlD
Flutamide—Constipation—Everolimus—kidney cancer	0.000207	0.00145	CcSEcCtD
Flutamide—Vomiting—Temsirolimus—kidney cancer	0.000207	0.00145	CcSEcCtD
Flutamide—Thrombocytopenia—Sorafenib—kidney cancer	0.000206	0.00144	CcSEcCtD
Flutamide—Rash—Temsirolimus—kidney cancer	0.000205	0.00144	CcSEcCtD
Flutamide—Dermatitis—Temsirolimus—kidney cancer	0.000205	0.00144	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000204	0.00143	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000204	0.00143	CcSEcCtD
Flutamide—Skin disorder—Sorafenib—kidney cancer	0.000204	0.00143	CcSEcCtD
Flutamide—Headache—Temsirolimus—kidney cancer	0.000204	0.00143	CcSEcCtD
Flutamide—Haematuria—Paclitaxel—kidney cancer	0.000203	0.00142	CcSEcCtD
Flutamide—Decreased appetite—Erlotinib—kidney cancer	0.000203	0.00142	CcSEcCtD
Flutamide—Dizziness—Pazopanib—kidney cancer	0.000203	0.00142	CcSEcCtD
Flutamide—Oedema—Sunitinib—kidney cancer	0.000202	0.00142	CcSEcCtD
Flutamide—Pulmonary embolism—Doxorubicin—kidney cancer	0.000202	0.00141	CcSEcCtD
Flutamide—Fatigue—Erlotinib—kidney cancer	0.000202	0.00141	CcSEcCtD
Flutamide—Anorexia—Sorafenib—kidney cancer	0.000201	0.0014	CcSEcCtD
Flutamide—Feeling abnormal—Vinblastine—kidney cancer	0.0002	0.0014	CcSEcCtD
Flutamide—Constipation—Erlotinib—kidney cancer	0.0002	0.0014	CcSEcCtD
Flutamide—Feeling abnormal—Everolimus—kidney cancer	0.0002	0.0014	CcSEcCtD
Flutamide—Erythema—Gemcitabine—kidney cancer	0.000199	0.00139	CcSEcCtD
Flutamide—Thrombocytopenia—Sunitinib—kidney cancer	0.000198	0.00139	CcSEcCtD
Flutamide—Discomfort—Dactinomycin—kidney cancer	0.000198	0.00138	CcSEcCtD
Flutamide—Cystitis noninfective—Doxorubicin—kidney cancer	0.000197	0.00138	CcSEcCtD
Flutamide—Skin disorder—Sunitinib—kidney cancer	0.000197	0.00138	CcSEcCtD
Flutamide—Vomiting—Pazopanib—kidney cancer	0.000195	0.00137	CcSEcCtD
Flutamide—Cystitis—Doxorubicin—kidney cancer	0.000195	0.00136	CcSEcCtD
Flutamide—Anaemia—Vincristine—kidney cancer	0.000194	0.00136	CcSEcCtD
Flutamide—Rash—Pazopanib—kidney cancer	0.000194	0.00135	CcSEcCtD
Flutamide—Nausea—Temsirolimus—kidney cancer	0.000194	0.00135	CcSEcCtD
Flutamide—Dermatitis—Pazopanib—kidney cancer	0.000193	0.00135	CcSEcCtD
Flutamide—Anorexia—Sunitinib—kidney cancer	0.000193	0.00135	CcSEcCtD
Flutamide—Headache—Pazopanib—kidney cancer	0.000192	0.00134	CcSEcCtD
Flutamide—Oedema—Dactinomycin—kidney cancer	0.000192	0.00134	CcSEcCtD
Flutamide—Blood urea increased—Doxorubicin—kidney cancer	0.00019	0.00133	CcSEcCtD
Flutamide—Oedema peripheral—Paclitaxel—kidney cancer	0.000189	0.00132	CcSEcCtD
Flutamide—Leukopenia—Vincristine—kidney cancer	0.000188	0.00131	CcSEcCtD
Flutamide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000188	0.00131	CcSEcCtD
Flutamide—Ill-defined disorder—Gemcitabine—kidney cancer	0.000185	0.00129	CcSEcCtD
Flutamide—Anaemia—Gemcitabine—kidney cancer	0.000184	0.00129	CcSEcCtD
Flutamide—Insomnia—Sunitinib—kidney cancer	0.000183	0.00128	CcSEcCtD
Flutamide—Decreased appetite—Sorafenib—kidney cancer	0.000183	0.00128	CcSEcCtD
Flutamide—Anorexia—Dactinomycin—kidney cancer	0.000183	0.00128	CcSEcCtD
Flutamide—Nausea—Pazopanib—kidney cancer	0.000182	0.00128	CcSEcCtD
Flutamide—Ecchymosis—Doxorubicin—kidney cancer	0.000182	0.00128	CcSEcCtD
Flutamide—Neoplasm—Doxorubicin—kidney cancer	0.000182	0.00128	CcSEcCtD
Flutamide—Bladder pain—Doxorubicin—kidney cancer	0.000182	0.00128	CcSEcCtD
Flutamide—Fatigue—Sorafenib—kidney cancer	0.000181	0.00127	CcSEcCtD
Flutamide—Hypertension—Vincristine—kidney cancer	0.000181	0.00127	CcSEcCtD
Flutamide—Constipation—Sorafenib—kidney cancer	0.00018	0.00126	CcSEcCtD
Flutamide—Malaise—Gemcitabine—kidney cancer	0.000179	0.00126	CcSEcCtD
Flutamide—Photosensitivity reaction—Capecitabine—kidney cancer	0.000179	0.00125	CcSEcCtD
Flutamide—Leukopenia—Gemcitabine—kidney cancer	0.000178	0.00125	CcSEcCtD
Flutamide—Hyperglycaemia—Capecitabine—kidney cancer	0.000177	0.00124	CcSEcCtD
Flutamide—Decreased appetite—Sunitinib—kidney cancer	0.000176	0.00123	CcSEcCtD
Flutamide—Asthenia—Vinblastine—kidney cancer	0.000175	0.00122	CcSEcCtD
Flutamide—Fatigue—Sunitinib—kidney cancer	0.000175	0.00122	CcSEcCtD
Flutamide—Asthenia—Everolimus—kidney cancer	0.000174	0.00122	CcSEcCtD
Flutamide—Constipation—Sunitinib—kidney cancer	0.000173	0.00121	CcSEcCtD
Flutamide—Hypertension—Gemcitabine—kidney cancer	0.000172	0.0012	CcSEcCtD
Flutamide—Pruritus—Everolimus—kidney cancer	0.000171	0.0012	CcSEcCtD
Flutamide—Oedema—Vincristine—kidney cancer	0.000171	0.0012	CcSEcCtD
Flutamide—Jaundice—Capecitabine—kidney cancer	0.000171	0.00119	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—kidney cancer	0.000168	0.00118	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000168	0.00118	CcSEcCtD
Flutamide—Asthenia—Erlotinib—kidney cancer	0.000168	0.00117	CcSEcCtD
Flutamide—Thrombocytopenia—Vincristine—kidney cancer	0.000168	0.00117	CcSEcCtD
Flutamide—Discomfort—Gemcitabine—kidney cancer	0.000167	0.00117	CcSEcCtD
Flutamide—Haematuria—Capecitabine—kidney cancer	0.000167	0.00117	CcSEcCtD
Flutamide—Erythema—Paclitaxel—kidney cancer	0.000167	0.00117	CcSEcCtD
Flutamide—Decreased appetite—Dactinomycin—kidney cancer	0.000167	0.00117	CcSEcCtD
Flutamide—Diarrhoea—Vinblastine—kidney cancer	0.000166	0.00116	CcSEcCtD
Flutamide—Diarrhoea—Everolimus—kidney cancer	0.000166	0.00116	CcSEcCtD
Flutamide—Pruritus—Erlotinib—kidney cancer	0.000165	0.00116	CcSEcCtD
Flutamide—Fatigue—Dactinomycin—kidney cancer	0.000165	0.00116	CcSEcCtD
Flutamide—Tension—Paclitaxel—kidney cancer	0.000164	0.00114	CcSEcCtD
Flutamide—Anorexia—Vincristine—kidney cancer	0.000163	0.00114	CcSEcCtD
Flutamide—Oedema—Gemcitabine—kidney cancer	0.000162	0.00114	CcSEcCtD
Flutamide—Nervousness—Paclitaxel—kidney cancer	0.000162	0.00113	CcSEcCtD
Flutamide—Dizziness—Vinblastine—kidney cancer	0.000161	0.00113	CcSEcCtD
Flutamide—Dizziness—Everolimus—kidney cancer	0.00016	0.00112	CcSEcCtD
Flutamide—Diarrhoea—Erlotinib—kidney cancer	0.00016	0.00112	CcSEcCtD
Flutamide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000159	0.00111	CcSEcCtD
Flutamide—Feeling abnormal—Dactinomycin—kidney cancer	0.000158	0.0011	CcSEcCtD
Flutamide—Skin disorder—Gemcitabine—kidney cancer	0.000158	0.0011	CcSEcCtD
Flutamide—Hepatitis—Capecitabine—kidney cancer	0.000157	0.0011	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—kidney cancer	0.000156	0.00109	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—kidney cancer	0.000156	0.00109	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—kidney cancer	0.000155	0.00108	CcSEcCtD
Flutamide—Insomnia—Vincristine—kidney cancer	0.000155	0.00108	CcSEcCtD
Flutamide—Anorexia—Gemcitabine—kidney cancer	0.000155	0.00108	CcSEcCtD
Flutamide—Oedema peripheral—Capecitabine—kidney cancer	0.000155	0.00108	CcSEcCtD
Flutamide—Vomiting—Vinblastine—kidney cancer	0.000155	0.00108	CcSEcCtD
Flutamide—Dizziness—Erlotinib—kidney cancer	0.000155	0.00108	CcSEcCtD
Flutamide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000155	0.00108	CcSEcCtD
Flutamide—Vomiting—Everolimus—kidney cancer	0.000154	0.00108	CcSEcCtD
Flutamide—Anaemia—Paclitaxel—kidney cancer	0.000154	0.00108	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—kidney cancer	0.000153	0.00107	CcSEcCtD
Flutamide—Rash—Everolimus—kidney cancer	0.000153	0.00107	CcSEcCtD
Flutamide—Dermatitis—Everolimus—kidney cancer	0.000153	0.00107	CcSEcCtD
Flutamide—Headache—Vinblastine—kidney cancer	0.000152	0.00107	CcSEcCtD
Flutamide—Headache—Everolimus—kidney cancer	0.000152	0.00106	CcSEcCtD
Flutamide—Asthenia—Sorafenib—kidney cancer	0.000151	0.00106	CcSEcCtD
Flutamide—Malaise—Paclitaxel—kidney cancer	0.00015	0.00105	CcSEcCtD
Flutamide—Leukopenia—Paclitaxel—kidney cancer	0.000149	0.00104	CcSEcCtD
Flutamide—Decreased appetite—Vincristine—kidney cancer	0.000149	0.00104	CcSEcCtD
Flutamide—Pruritus—Sorafenib—kidney cancer	0.000149	0.00104	CcSEcCtD
Flutamide—Vomiting—Erlotinib—kidney cancer	0.000149	0.00104	CcSEcCtD
Flutamide—Fatigue—Vincristine—kidney cancer	0.000148	0.00103	CcSEcCtD
Flutamide—Rash—Erlotinib—kidney cancer	0.000147	0.00103	CcSEcCtD
Flutamide—Dermatitis—Erlotinib—kidney cancer	0.000147	0.00103	CcSEcCtD
Flutamide—Insomnia—Gemcitabine—kidney cancer	0.000147	0.00103	CcSEcCtD
Flutamide—Headache—Erlotinib—kidney cancer	0.000146	0.00102	CcSEcCtD
Flutamide—Constipation—Vincristine—kidney cancer	0.000146	0.00102	CcSEcCtD
Flutamide—Asthenia—Sunitinib—kidney cancer	0.000145	0.00102	CcSEcCtD
Flutamide—Nausea—Vinblastine—kidney cancer	0.000145	0.00101	CcSEcCtD
Flutamide—Somnolence—Gemcitabine—kidney cancer	0.000144	0.00101	CcSEcCtD
Flutamide—Nausea—Everolimus—kidney cancer	0.000144	0.00101	CcSEcCtD
Flutamide—Diarrhoea—Sorafenib—kidney cancer	0.000144	0.00101	CcSEcCtD
Flutamide—Hypertension—Paclitaxel—kidney cancer	0.000144	0.00101	CcSEcCtD
Flutamide—Pruritus—Sunitinib—kidney cancer	0.000143	0.001	CcSEcCtD
Flutamide—Anxiety—Paclitaxel—kidney cancer	0.000141	0.000989	CcSEcCtD
Flutamide—Decreased appetite—Gemcitabine—kidney cancer	0.000141	0.000988	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000141	0.000985	CcSEcCtD
Flutamide—Discomfort—Paclitaxel—kidney cancer	0.00014	0.00098	CcSEcCtD
Flutamide—Fatigue—Gemcitabine—kidney cancer	0.00014	0.000979	CcSEcCtD
Flutamide—Dizziness—Sorafenib—kidney cancer	0.000139	0.000973	CcSEcCtD
Flutamide—Constipation—Gemcitabine—kidney cancer	0.000139	0.000972	CcSEcCtD
Flutamide—Nausea—Erlotinib—kidney cancer	0.000139	0.000972	CcSEcCtD
Flutamide—Diarrhoea—Sunitinib—kidney cancer	0.000138	0.000969	CcSEcCtD
Flutamide—Asthenia—Dactinomycin—kidney cancer	0.000137	0.000962	CcSEcCtD
Flutamide—Confusional state—Paclitaxel—kidney cancer	0.000137	0.000959	CcSEcCtD
Flutamide—Erythema—Capecitabine—kidney cancer	0.000137	0.000956	CcSEcCtD
Flutamide—Oedema—Paclitaxel—kidney cancer	0.000136	0.000951	CcSEcCtD
Flutamide—Dizziness—Sunitinib—kidney cancer	0.000134	0.000936	CcSEcCtD
Flutamide—Feeling abnormal—Gemcitabine—kidney cancer	0.000134	0.000936	CcSEcCtD
Flutamide—Vomiting—Sorafenib—kidney cancer	0.000134	0.000936	CcSEcCtD
Flutamide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000133	0.000931	CcSEcCtD
Flutamide—Rash—Sorafenib—kidney cancer	0.000133	0.000928	CcSEcCtD
Flutamide—Dermatitis—Sorafenib—kidney cancer	0.000133	0.000927	CcSEcCtD
Flutamide—Skin disorder—Paclitaxel—kidney cancer	0.000132	0.000924	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000132	0.000922	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000132	0.000922	CcSEcCtD
Flutamide—Headache—Sorafenib—kidney cancer	0.000132	0.000922	CcSEcCtD
Flutamide—Diarrhoea—Dactinomycin—kidney cancer	0.000131	0.000917	CcSEcCtD
Flutamide—Anorexia—Paclitaxel—kidney cancer	0.00013	0.000907	CcSEcCtD
Flutamide—Vomiting—Sunitinib—kidney cancer	0.000129	0.0009	CcSEcCtD
Flutamide—Rash—Sunitinib—kidney cancer	0.000128	0.000893	CcSEcCtD
Flutamide—Dermatitis—Sunitinib—kidney cancer	0.000128	0.000892	CcSEcCtD
Flutamide—Ill-defined disorder—Capecitabine—kidney cancer	0.000127	0.000887	CcSEcCtD
Flutamide—Headache—Sunitinib—kidney cancer	0.000127	0.000887	CcSEcCtD
Flutamide—Anaemia—Capecitabine—kidney cancer	0.000126	0.000884	CcSEcCtD
Flutamide—Nausea—Sorafenib—kidney cancer	0.000125	0.000874	CcSEcCtD
Flutamide—Malaise—Capecitabine—kidney cancer	0.000123	0.000863	CcSEcCtD
Flutamide—Insomnia—Paclitaxel—kidney cancer	0.000123	0.00086	CcSEcCtD
Flutamide—Asthenia—Vincristine—kidney cancer	0.000123	0.000859	CcSEcCtD
Flutamide—Leukopenia—Capecitabine—kidney cancer	0.000122	0.000856	CcSEcCtD
Flutamide—Vomiting—Dactinomycin—kidney cancer	0.000122	0.000852	CcSEcCtD
Flutamide—Somnolence—Paclitaxel—kidney cancer	0.000121	0.000846	CcSEcCtD
Flutamide—Rash—Dactinomycin—kidney cancer	0.000121	0.000845	CcSEcCtD
Flutamide—Nausea—Sunitinib—kidney cancer	0.00012	0.000841	CcSEcCtD
Flutamide—Decreased appetite—Paclitaxel—kidney cancer	0.000118	0.000827	CcSEcCtD
Flutamide—Hypertension—Capecitabine—kidney cancer	0.000118	0.000826	CcSEcCtD
Flutamide—Fatigue—Paclitaxel—kidney cancer	0.000117	0.00082	CcSEcCtD
Flutamide—Diarrhoea—Vincristine—kidney cancer	0.000117	0.000819	CcSEcCtD
Flutamide—Asthenia—Gemcitabine—kidney cancer	0.000117	0.000815	CcSEcCtD
Flutamide—Constipation—Paclitaxel—kidney cancer	0.000116	0.000813	CcSEcCtD
Flutamide—Anxiety—Capecitabine—kidney cancer	0.000116	0.000811	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000116	0.000809	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000115	0.000808	CcSEcCtD
Flutamide—Discomfort—Capecitabine—kidney cancer	0.000115	0.000805	CcSEcCtD
Flutamide—Pruritus—Gemcitabine—kidney cancer	0.000115	0.000804	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000114	0.000798	CcSEcCtD
Flutamide—Nausea—Dactinomycin—kidney cancer	0.000114	0.000796	CcSEcCtD
Flutamide—Dizziness—Vincristine—kidney cancer	0.000113	0.000792	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—kidney cancer	0.000113	0.000789	CcSEcCtD
Flutamide—Confusional state—Capecitabine—kidney cancer	0.000113	0.000787	CcSEcCtD
Flutamide—Feeling abnormal—Paclitaxel—kidney cancer	0.000112	0.000784	CcSEcCtD
Flutamide—Oedema—Capecitabine—kidney cancer	0.000112	0.000781	CcSEcCtD
Flutamide—Diarrhoea—Gemcitabine—kidney cancer	0.000111	0.000777	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—kidney cancer	0.00011	0.000769	CcSEcCtD
Flutamide—Thrombocytopenia—Capecitabine—kidney cancer	0.000109	0.000764	CcSEcCtD
Flutamide—Vomiting—Vincristine—kidney cancer	0.000109	0.000761	CcSEcCtD
Flutamide—Skin disorder—Capecitabine—kidney cancer	0.000108	0.000758	CcSEcCtD
Flutamide—Rash—Vincristine—kidney cancer	0.000108	0.000755	CcSEcCtD
Flutamide—Dermatitis—Vincristine—kidney cancer	0.000108	0.000754	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—kidney cancer	0.000108	0.000752	CcSEcCtD
Flutamide—Headache—Vincristine—kidney cancer	0.000107	0.00075	CcSEcCtD
Flutamide—Anorexia—Capecitabine—kidney cancer	0.000106	0.000744	CcSEcCtD
Flutamide—Vomiting—Gemcitabine—kidney cancer	0.000103	0.000722	CcSEcCtD
Flutamide—Rash—Gemcitabine—kidney cancer	0.000102	0.000716	CcSEcCtD
Flutamide—Dermatitis—Gemcitabine—kidney cancer	0.000102	0.000716	CcSEcCtD
Flutamide—Headache—Gemcitabine—kidney cancer	0.000102	0.000712	CcSEcCtD
Flutamide—Nausea—Vincristine—kidney cancer	0.000102	0.000711	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—kidney cancer	0.000101	0.000708	CcSEcCtD
Flutamide—Insomnia—Capecitabine—kidney cancer	0.000101	0.000706	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—kidney cancer	9.97e-05	0.000698	CcSEcCtD
Flutamide—Asthenia—Paclitaxel—kidney cancer	9.76e-05	0.000682	CcSEcCtD
Flutamide—Decreased appetite—Capecitabine—kidney cancer	9.7e-05	0.000679	CcSEcCtD
Flutamide—Nausea—Gemcitabine—kidney cancer	9.65e-05	0.000675	CcSEcCtD
Flutamide—Fatigue—Capecitabine—kidney cancer	9.62e-05	0.000673	CcSEcCtD
Flutamide—Pruritus—Paclitaxel—kidney cancer	9.62e-05	0.000673	CcSEcCtD
Flutamide—Constipation—Capecitabine—kidney cancer	9.54e-05	0.000668	CcSEcCtD
Flutamide—Diarrhoea—Paclitaxel—kidney cancer	9.3e-05	0.000651	CcSEcCtD
Flutamide—Feeling abnormal—Capecitabine—kidney cancer	9.2e-05	0.000643	CcSEcCtD
Flutamide—Dizziness—Paclitaxel—kidney cancer	8.99e-05	0.000629	CcSEcCtD
Flutamide—Erythema—Doxorubicin—kidney cancer	8.81e-05	0.000617	CcSEcCtD
Flutamide—Tension—Doxorubicin—kidney cancer	8.65e-05	0.000605	CcSEcCtD
Flutamide—Vomiting—Paclitaxel—kidney cancer	8.65e-05	0.000605	CcSEcCtD
Flutamide—Rash—Paclitaxel—kidney cancer	8.57e-05	0.0006	CcSEcCtD
Flutamide—Dermatitis—Paclitaxel—kidney cancer	8.57e-05	0.000599	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—kidney cancer	8.56e-05	0.000599	CcSEcCtD
Flutamide—Headache—Paclitaxel—kidney cancer	8.52e-05	0.000596	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—kidney cancer	8.18e-05	0.000572	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—kidney cancer	8.15e-05	0.00057	CcSEcCtD
Flutamide—Nausea—Paclitaxel—kidney cancer	8.08e-05	0.000565	CcSEcCtD
Flutamide—Asthenia—Capecitabine—kidney cancer	8.01e-05	0.00056	CcSEcCtD
Flutamide—Malaise—Doxorubicin—kidney cancer	7.95e-05	0.000556	CcSEcCtD
Flutamide—Pruritus—Capecitabine—kidney cancer	7.9e-05	0.000552	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—kidney cancer	7.89e-05	0.000552	CcSEcCtD
Flutamide—Diarrhoea—Capecitabine—kidney cancer	7.64e-05	0.000534	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—kidney cancer	7.61e-05	0.000532	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—kidney cancer	7.48e-05	0.000523	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.45e-05	0.000521	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—kidney cancer	7.41e-05	0.000519	CcSEcCtD
Flutamide—Dizziness—Capecitabine—kidney cancer	7.38e-05	0.000516	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—kidney cancer	7.25e-05	0.000507	CcSEcCtD
Flutamide—Oedema—Doxorubicin—kidney cancer	7.19e-05	0.000503	CcSEcCtD
Flutamide—Vomiting—Capecitabine—kidney cancer	7.1e-05	0.000496	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—kidney cancer	7.04e-05	0.000493	CcSEcCtD
Flutamide—Rash—Capecitabine—kidney cancer	7.04e-05	0.000492	CcSEcCtD
Flutamide—Dermatitis—Capecitabine—kidney cancer	7.03e-05	0.000492	CcSEcCtD
Flutamide—Headache—Capecitabine—kidney cancer	6.99e-05	0.000489	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—kidney cancer	6.99e-05	0.000489	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—kidney cancer	6.86e-05	0.00048	CcSEcCtD
Flutamide—Nausea—Capecitabine—kidney cancer	6.63e-05	0.000464	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—kidney cancer	6.51e-05	0.000455	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—kidney cancer	6.39e-05	0.000447	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—kidney cancer	6.25e-05	0.000437	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—kidney cancer	6.2e-05	0.000434	CcSEcCtD
Flutamide—Constipation—Doxorubicin—kidney cancer	6.15e-05	0.00043	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—kidney cancer	5.93e-05	0.000415	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—kidney cancer	5.16e-05	0.000361	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—kidney cancer	5.09e-05	0.000356	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—kidney cancer	4.92e-05	0.000344	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—kidney cancer	4.76e-05	0.000333	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—kidney cancer	4.57e-05	0.00032	CcSEcCtD
Flutamide—Rash—Doxorubicin—kidney cancer	4.54e-05	0.000317	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—kidney cancer	4.53e-05	0.000317	CcSEcCtD
Flutamide—Headache—Doxorubicin—kidney cancer	4.51e-05	0.000315	CcSEcCtD
Flutamide—Nausea—Doxorubicin—kidney cancer	4.27e-05	0.000299	CcSEcCtD
Flutamide—CYP1B1—Metabolism—SLC5A3—kidney cancer	2.96e-05	0.000486	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.96e-05	0.000485	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PDHB—kidney cancer	2.95e-05	0.000484	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—POMC—kidney cancer	2.94e-05	0.000483	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CCBL1—kidney cancer	2.93e-05	0.000482	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—LDHB—kidney cancer	2.9e-05	0.000476	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.88e-05	0.000474	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.87e-05	0.000472	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.84e-05	0.000467	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ACY1—kidney cancer	2.84e-05	0.000466	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.83e-05	0.000464	CbGpPWpGaD
Flutamide—AR—Gene Expression—HSPB1—kidney cancer	2.78e-05	0.000457	CbGpPWpGaD
Flutamide—AR—Gene Expression—EIF4EBP1—kidney cancer	2.78e-05	0.000457	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CCBL1—kidney cancer	2.77e-05	0.000455	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.72e-05	0.000447	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.65e-05	0.000435	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.61e-05	0.000429	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.6e-05	0.000427	CbGpPWpGaD
Flutamide—AR—Gene Expression—PSMD7—kidney cancer	2.58e-05	0.000424	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPAT—kidney cancer	2.54e-05	0.000418	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GLIPR1—kidney cancer	2.54e-05	0.000418	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CA9—kidney cancer	2.51e-05	0.000413	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.51e-05	0.000413	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.51e-05	0.000413	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.51e-05	0.000412	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.48e-05	0.000407	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.46e-05	0.000404	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.42e-05	0.000397	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PDHB—kidney cancer	2.41e-05	0.000396	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—POMC—kidney cancer	2.4e-05	0.000395	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPAT—kidney cancer	2.4e-05	0.000395	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GLIPR1—kidney cancer	2.4e-05	0.000395	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.37e-05	0.00039	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—APRT—kidney cancer	2.36e-05	0.000388	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—FH—kidney cancer	2.36e-05	0.000388	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.35e-05	0.000386	CbGpPWpGaD
Flutamide—AR—Gene Expression—JUNB—kidney cancer	2.32e-05	0.000381	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CCBL1—kidney cancer	2.27e-05	0.000372	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—FH—kidney cancer	2.23e-05	0.000367	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—APRT—kidney cancer	2.23e-05	0.000367	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.23e-05	0.000366	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GPC3—kidney cancer	2.22e-05	0.000365	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ACY1—kidney cancer	2.21e-05	0.000363	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.19e-05	0.000361	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.18e-05	0.000359	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA2—kidney cancer	2.16e-05	0.000355	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CRABP1—kidney cancer	2.14e-05	0.000351	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALAD—kidney cancer	2.11e-05	0.000346	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GPC3—kidney cancer	2.1e-05	0.000345	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ST3GAL2—kidney cancer	2.06e-05	0.000338	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.05e-05	0.000337	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.04e-05	0.000336	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA2—kidney cancer	2.04e-05	0.000335	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.02e-05	0.000331	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALDH1A1—kidney cancer	2.01e-05	0.00033	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALAD—kidney cancer	1.99e-05	0.000327	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ITPR2—kidney cancer	1.99e-05	0.000326	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPAT—kidney cancer	1.97e-05	0.000323	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.97e-05	0.000323	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ST3GAL2—kidney cancer	1.94e-05	0.000319	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.94e-05	0.000319	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.94e-05	0.000318	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PGK1—kidney cancer	1.93e-05	0.000317	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.93e-05	0.000317	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.92e-05	0.000316	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.91e-05	0.000314	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALDH1A1—kidney cancer	1.9e-05	0.000312	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—LDHB—kidney cancer	1.89e-05	0.00031	CbGpPWpGaD
Flutamide—AR—Gene Expression—CDKN2B—kidney cancer	1.89e-05	0.00031	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.88e-05	0.00031	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PDHB—kidney cancer	1.88e-05	0.000309	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—POMC—kidney cancer	1.87e-05	0.000308	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.83e-05	0.000301	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—FH—kidney cancer	1.83e-05	0.0003	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—APRT—kidney cancer	1.83e-05	0.0003	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PGK1—kidney cancer	1.82e-05	0.000299	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC5A3—kidney cancer	1.82e-05	0.000299	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTT1—kidney cancer	1.81e-05	0.000298	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ACHE—kidney cancer	1.81e-05	0.000298	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.79e-05	0.000293	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—LDHB—kidney cancer	1.79e-05	0.000293	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CCBL1—kidney cancer	1.77e-05	0.00029	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GPC3—kidney cancer	1.72e-05	0.000282	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SCARB1—kidney cancer	1.71e-05	0.000282	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ACY1—kidney cancer	1.71e-05	0.00028	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS1—kidney cancer	1.7e-05	0.000279	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA2—kidney cancer	1.67e-05	0.000275	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSMD7—kidney cancer	1.66e-05	0.000273	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA9—kidney cancer	1.64e-05	0.000269	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALAD—kidney cancer	1.63e-05	0.000268	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.6e-05	0.000262	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.59e-05	0.000261	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—BCHE—kidney cancer	1.58e-05	0.000259	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SLC5A5—kidney cancer	1.56e-05	0.000256	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.55e-05	0.000255	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA9—kidney cancer	1.55e-05	0.000254	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPAT—kidney cancer	1.53e-05	0.000252	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.53e-05	0.000252	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—kidney cancer	1.52e-05	0.00025	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.51e-05	0.000248	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SLC2A1—kidney cancer	1.51e-05	0.000247	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.5e-05	0.000246	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.49e-05	0.000245	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PGK1—kidney cancer	1.49e-05	0.000245	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.46e-05	0.00024	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—LDHB—kidney cancer	1.46e-05	0.00024	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PDHB—kidney cancer	1.45e-05	0.000238	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.45e-05	0.000237	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—APRT—kidney cancer	1.42e-05	0.000234	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—FH—kidney cancer	1.42e-05	0.000234	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CRABP1—kidney cancer	1.39e-05	0.000229	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.39e-05	0.000229	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CCBL1—kidney cancer	1.36e-05	0.000224	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GPC3—kidney cancer	1.34e-05	0.00022	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CRABP1—kidney cancer	1.32e-05	0.000216	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA2—kidney cancer	1.3e-05	0.000214	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ITPR2—kidney cancer	1.3e-05	0.000213	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.27e-05	0.000209	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALAD—kidney cancer	1.27e-05	0.000208	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA9—kidney cancer	1.27e-05	0.000208	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTP1—kidney cancer	1.26e-05	0.000206	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000203	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.24e-05	0.000203	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ITPR2—kidney cancer	1.22e-05	0.000201	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.000199	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCB1—kidney cancer	1.19e-05	0.000195	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.18e-05	0.000194	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPAT—kidney cancer	1.18e-05	0.000194	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ACHE—kidney cancer	1.18e-05	0.000194	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—kidney cancer	1.18e-05	0.000194	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.000191	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PGK1—kidney cancer	1.16e-05	0.000191	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTM1—kidney cancer	1.15e-05	0.00019	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—LDHB—kidney cancer	1.14e-05	0.000187	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.13e-05	0.000185	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SCARB1—kidney cancer	1.12e-05	0.000184	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ACHE—kidney cancer	1.12e-05	0.000183	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—kidney cancer	1.12e-05	0.000183	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS1—kidney cancer	1.11e-05	0.000182	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—FH—kidney cancer	1.1e-05	0.000181	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—APRT—kidney cancer	1.1e-05	0.000181	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP1A1—kidney cancer	1.09e-05	0.00018	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSMD7—kidney cancer	1.09e-05	0.000178	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CRABP1—kidney cancer	1.08e-05	0.000177	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SCARB1—kidney cancer	1.06e-05	0.000173	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS1—kidney cancer	1.05e-05	0.000172	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPC3—kidney cancer	1.03e-05	0.00017	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—BCHE—kidney cancer	1.03e-05	0.000169	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSMD7—kidney cancer	1.03e-05	0.000168	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.02e-05	0.000167	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA2—kidney cancer	1.01e-05	0.000165	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ITPR2—kidney cancer	1e-05	0.000164	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA9—kidney cancer	9.87e-06	0.000162	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC2A1—kidney cancer	9.81e-06	0.000161	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALAD—kidney cancer	9.79e-06	0.000161	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—BCHE—kidney cancer	9.72e-06	0.00016	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.65e-06	0.000158	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC5A5—kidney cancer	9.6e-06	0.000158	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.56e-06	0.000157	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.34e-06	0.000153	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC2A1—kidney cancer	9.27e-06	0.000152	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.23e-06	0.000152	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ACHE—kidney cancer	9.13e-06	0.00015	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—kidney cancer	9.13e-06	0.00015	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9e-06	0.000148	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.99e-06	0.000148	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.96e-06	0.000147	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PGK1—kidney cancer	8.96e-06	0.000147	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—LDHB—kidney cancer	8.78e-06	0.000144	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SCARB1—kidney cancer	8.64e-06	0.000142	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS1—kidney cancer	8.56e-06	0.000141	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CRABP1—kidney cancer	8.39e-06	0.000138	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSMD7—kidney cancer	8.39e-06	0.000138	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—kidney cancer	8.19e-06	0.000134	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—POMC—kidney cancer	8.16e-06	0.000134	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—BCHE—kidney cancer	7.95e-06	0.000131	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC5A5—kidney cancer	7.86e-06	0.000129	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.85e-06	0.000129	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ITPR2—kidney cancer	7.8e-06	0.000128	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—kidney cancer	7.75e-06	0.000127	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—kidney cancer	7.73e-06	0.000127	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA9—kidney cancer	7.62e-06	0.000125	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.59e-06	0.000125	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAPK3—kidney cancer	7.52e-06	0.000124	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—kidney cancer	7.52e-06	0.000124	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.36e-06	0.000121	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—kidney cancer	7.32e-06	0.00012	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—kidney cancer	7.32e-06	0.00012	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.19e-06	0.000118	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1A1—kidney cancer	7.13e-06	0.000117	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—kidney cancer	7.11e-06	0.000117	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ACHE—kidney cancer	7.11e-06	0.000117	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—kidney cancer	7.11e-06	0.000117	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SCARB1—kidney cancer	6.73e-06	0.000111	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS1—kidney cancer	6.67e-06	0.00011	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSMD7—kidney cancer	6.54e-06	0.000107	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—kidney cancer	6.51e-06	0.000107	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CRABP1—kidney cancer	6.48e-06	0.000106	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.42e-06	0.000105	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—kidney cancer	6.33e-06	0.000104	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—BCHE—kidney cancer	6.2e-06	0.000102	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC5A5—kidney cancer	6.12e-06	0.000101	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ITPR2—kidney cancer	6.02e-06	9.89e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—kidney cancer	5.99e-06	9.84e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.91e-06	9.71e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—kidney cancer	5.82e-06	9.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.74e-06	9.42e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—kidney cancer	5.67e-06	9.32e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.53e-06	9.09e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.51e-06	9.06e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ACHE—kidney cancer	5.49e-06	9.02e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—kidney cancer	5.49e-06	9.02e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—POMC—kidney cancer	5.32e-06	8.73e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SCARB1—kidney cancer	5.2e-06	8.54e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS1—kidney cancer	5.14e-06	8.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSMD7—kidney cancer	5.05e-06	8.29e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—POMC—kidney cancer	5.02e-06	8.25e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5e-06	8.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—kidney cancer	4.93e-06	8.1e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BCHE—kidney cancer	4.78e-06	7.86e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.72e-06	7.76e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—kidney cancer	4.67e-06	7.67e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.56e-06	7.5e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—kidney cancer	4.53e-06	7.44e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.53e-06	7.44e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.3e-06	7.06e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—kidney cancer	4.24e-06	6.97e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—POMC—kidney cancer	4.11e-06	6.75e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—kidney cancer	4.01e-06	6.58e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—kidney cancer	4e-06	6.58e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—kidney cancer	3.81e-06	6.25e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—kidney cancer	3.7e-06	6.08e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—kidney cancer	3.6e-06	5.92e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.53e-06	5.8e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—kidney cancer	3.5e-06	5.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—kidney cancer	3.49e-06	5.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.32e-06	5.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—kidney cancer	3.28e-06	5.39e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—POMC—kidney cancer	3.2e-06	5.26e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—kidney cancer	2.86e-06	4.7e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.61e-06	4.29e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—kidney cancer	2.55e-06	4.2e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—POMC—kidney cancer	2.47e-06	4.06e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—kidney cancer	2.46e-06	4.05e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—kidney cancer	2.23e-06	3.66e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.02e-06	3.31e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.97e-06	3.24e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—kidney cancer	1.72e-06	2.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.57e-06	2.58e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.21e-06	1.99e-05	CbGpPWpGaD
